![]()
|
|
||||||||
(Received for publication, September 6, 1996, and in revised form, September 23, 1996)
From the Department of Biochemistry, University of Connecticut
Health Center, Farmington, Connecticut 06032
p16INK4 is a specific cyclin
D-dependent kinase inhibitor and a multiple tumor
suppressor. Inactivation of p16 is frequent in both primary tumors and
tumor-derived cell lines. We describe here the conformational
properties and oligomerization state of seven mutant p16 proteins; all
of them are deficient in function. Four of the seven proteins show
significantly disrupted secondary structure and backbone folding. The
other three adopt partially folded, molten globule-like conformations.
These proteins have near-native levels of secondary structure, but lack
the ability to undergo a cooperative thermal transition and are
substantially less resistant to proteolysis than is wild type p16. At
low concentrations, two of the seven proteins are monomers, three
exhibit an apparent molecular weight between the value of a monomer and
a dimer, and the other two aggregate significantly. Our results
strongly suggest that defective protein folding and/or aggregation is a
common mechanism for inactivation of p16.
Volume 271, Number 46,
Issue of November 15, 1996
pp. 28734-28737
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
COMMUNICATION:
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
O. Y. Lubman, R. Kopan, G. Waksman, and S. Korolev The crystal structure of a partial mouse Notch-1 ankyrin domain: Repeats 4 through 7 preserve an ankyrin fold Protein Sci., May 1, 2005; 14(5): 1274 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Croy, S. Bergqvist, T. Huxford, G. Ghosh, and E. A. Komives Biophysical characterization of the free I{kappa}B{alpha} ankyrin repeat domain in solution Protein Sci., July 1, 2004; 13(7): 1767 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Mosavi, T. J. Cammett, D. C. Desrosiers, and Z.-y. Peng The ankyrin repeat as molecular architecture for protein recognition Protein Sci., June 1, 2004; 13(6): 1435 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Seimiya, Y. Muramatsu, S. Smith, and T. Tsuruo Functional Subdomain in the Ankyrin Domain of Tankyrase 1 Required for Poly(ADP-Ribosyl)ation of TRF1 and Telomere Elongation Mol. Cell. Biol., March 1, 2004; 24(5): 1944 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Mosavi, D. L. Minor Jr., and Z.-y. Peng Consensus-derived structural determinants of the ankyrin repeat motif PNAS, December 10, 2002; 99(25): 16029 - 16034. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Venkataramani, T. K. MacLachlan, X. Chai, W. S. El-Deiry, and R. Marmorstein Structure-based Design of p18INK4c Proteins with Increased Thermodynamic Stability and Cell Cycle Inhibitory Activity J. Biol. Chem., December 6, 2002; 277(50): 48827 - 48833. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Seimiya and S. Smith The Telomeric Poly(ADP-ribose) Polymerase, Tankyrase 1, Contains Multiple Binding Sites for Telomeric Repeat Binding Factor 1 (TRF1) and a Novel Acceptor, 182-kDa Tankyrase-binding Protein (TAB182) J. Biol. Chem., April 12, 2002; 277(16): 14116 - 14126. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bagyan and P. Setlow Localization of the Cortex Lytic Enzyme CwlJ in Spores of Bacillus subtilis J. Bacteriol., February 15, 2002; 184(4): 1219 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Becker, H. Rizos, R. F. Kefford, and G. J. Mann Functional Impairment of Melanoma-associated p16INK4a Mutants in Melanoma Cells despite Retention of Cyclin-dependent Kinase 4 Binding Clin. Cancer Res., October 1, 2001; 7(10): 3282 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-M. Georgescu, K. H. Kirsch, T. Akagi, T. Shishido, and H. Hanafusa The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region PNAS, August 31, 1999; 96(18): 10182 - 10187. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Huschtscha and R. R. Reddel p16INK4a and the control of cellular proliferative life span Carcinogenesis, June 1, 1999; 20(6): 921 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Noh, Y. Li, Y. Xiong, and K.-L. Guan Identification of Functional Elements of p18INK4C Essential for Binding and Inhibition of Cyclin-dependent Kinase (CDK) 4 and CDK6 Cancer Res., February 1, 1999; 59(3): 558 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, E. S. Ramsay, and B. A. Mock Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1 PNAS, March 3, 1998; 95(5): 2429 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Urashima, J. A. DeCaprio, D. Chauhan, G. Teoh, A. Ogata, S. P. Treon, Y. Hoshi, and K. C. Anderson p16INK4A Promotes Differentiation and Inhibits Apoptosis of JKB Acute Lymphoblastic Leukemia Cells Blood, November 15, 1997; 90(10): 4106 - 4115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |